SamanTree Medical raises CHF 9.5 million to assess the margins in cancer surgery

Written By Marie Suard

6th May 2019

Following the promising clinical results achieved with its CE mark device, SamanTree Medical has recently closed a CHF 9.5 Million Series A financing round for developing its commercial operations.

Press release here.

Marie Suard
Previous

Promising results on breast biopsies published
Next

CE Mark for Histolog™ Scanner new version